Literature DB >> 11344009

Development of functional electrical stimulators utilizing cochlear implant technology.

R Davis1, J Patrick, A Barriskill.   

Abstract

In 1983, R. Davis proposed the development of a functional electrical stimulator, based on multi-channel cochlear implant technology, for the restoration of function in spinal cord injured paraplegic subjects. In 1984, the US Veteran Administration funded the initial investigations including animal experiments and purchase of a FES stimulator based on the Nucleus 22 cochlear implant. In 1987, the US Food and Drug Administration approved an Investigational Device Exemption (IDE# G870142) for this FES project. In 1991, the first stimulator was implanted in a 21-year old male paraplegic subject (complete thoracic spinal cord lesion at level #10), who was subsequently able to stand and to perform one-handed tasks for up to 1h. In 1996-1997 development started on a new multi-function FES system. In 1998, a stimulator was implanted in a 35-year-old male paraplegic subject (complete thoracic spinal cord lesion at level #10). After 8 months of use providing multiple functions including bladder voiding, the implant's internal antenna wire broke. A modified implant (FES 24-B) is due to be implanted in July 2001.

Entities:  

Mesh:

Year:  2001        PMID: 11344009     DOI: 10.1016/s1350-4533(01)00023-6

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  3 in total

Review 1.  Role of electrical stimulation for rehabilitation and regeneration after spinal cord injury: an overview.

Authors:  Samar Hamid; Ray Hayek
Journal:  Eur Spine J       Date:  2008-08-02       Impact factor: 3.134

2.  The effects of stimulation frequency and fatigue on the force-intensity relationship for human skeletal muscle.

Authors:  Li-Wei Chou; Stuart A Binder-Macleod
Journal:  Clin Neurophysiol       Date:  2007-04-26       Impact factor: 3.708

Review 3.  Neuromodulation of lower limb motor control in restorative neurology.

Authors:  Karen Minassian; Ursula Hofstoetter; Keith Tansey; Winfried Mayr
Journal:  Clin Neurol Neurosurg       Date:  2012-03-29       Impact factor: 1.876

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.